Insider · CIK 0001845965
Agarwala Sandip
Reports to the SEC for 1 company · LOUISVILLE, KY
Transactions
7
Companies
1
Filings
3
CIK
0001845965
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2023-06-13 | TRMLTourmaline Bio, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-06-09 | TRMLTourmaline Bio, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-05-11 | TRMLTourmaline Bio, Inc.P Purchase | +$4M |
| 2021-05-11 | TRMLTourmaline Bio, Inc. · Series A-1 Preferred StockC Conversion | — |
| 2021-05-11 | TRMLTourmaline Bio, Inc. · Series B Preferred StockC Conversion | — |
| 2021-05-11 | TRMLTourmaline Bio, Inc. · Series A Preferred StockC Conversion | — |
| 2021-05-11 | TRMLTourmaline Bio, Inc.C Conversion | — |
Recent filings
- 4Agarwala Sandip0001209191-23-037182SEC(opens sec.gov)
- 4Agarwala Sandip0000899243-22-022245SEC(opens sec.gov)
- 4Agarwala Sandip0000899243-21-019167SEC(opens sec.gov)
Companies
Address
C/O TALARIS THERAPEUTICS, INC. 570 S. PRESTON STREET
LOUISVILLE, KY, 40202